HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Natalie D Ritchie Selected Research

4-nitro-3-dimethylaminopropiophenone

9/2022Promises and Pitfalls of Dyads in the National Diabetes Prevention Program: Lifestyle Coach Perspectives.
11/2021Patient-Centered Goal-Setting in the National Diabetes Prevention Program: A Pilot Study.
1/2021Participation and weight loss in online National Diabetes Prevention Programs: a comparison of age and gender subgroups.
6/2020Enhanced Enrollment in the National Diabetes Prevention Program to Increase Engagement and Weight Loss for the Underserved: Protocol for a Randomized Controlled Trial.
1/2020Supplemental Text Message Support With the National Diabetes Prevention Program: Pragmatic Comparative Effectiveness Trial.
1/2020Current Perspectives on the Impact of the National Diabetes Prevention Program: Building on Successes and Overcoming Challenges.
4/2019Short Message Service Text Message Support for Weight Loss in Patients With Prediabetes: Pragmatic Trial.
1/2019Presessions to the National Diabetes Prevention Program May be a Promising Strategy to Improve Attendance and Weight Loss Outcomes.
11/2018Effects of physical activity goal attainment on engagement and outcomes in the National Diabetes Prevention Program.
1/2018Effect of the National Diabetes Prevention Program on Weight Loss for English- and Spanish-Speaking Latinos.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Natalie D Ritchie Research Topics

Disease

8Weight Loss (Weight Reduction)
11/2021 - 01/2018
4Type 2 Diabetes Mellitus (MODY)
10/2022 - 01/2020
3Prediabetic State (Prediabetes)
01/2020 - 11/2018
1Insulin Resistance
01/2021

Drug/Important Bio-Agent (IBA)

104-nitro-3-dimethylaminopropiophenoneIBA
09/2022 - 01/2018
22- methyl- 1,1- diphenyl- 3- (1- pyrrolidyl)- 1- propanol (MDPP)IBA
01/2020 - 11/2018
1Metformin (Glucophage)FDA LinkGeneric
10/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2021

Therapy/Procedure

1Bariatric Surgery
10/2022